tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Phathom Pharmaceuticals Inc

PHAT
Add to Watchlist
8.930USD
+0.180+2.06%
Close 07-31 16:00（ET）Quotes delayed by 15 min
715.03MMarket Cap
LossP/E TTM

Phathom Pharmaceuticals Inc

8.930
+0.180+2.06%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

PHAT Financials

See Phathom Pharmaceuticals Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Phathom Pharmaceuticals Inc Earnings Date

Latest Release
Jul 30, 2026
EPS / Forecast
-0.21/-0.25
Revenue / Forecast
74.27M/72.79M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
175.11M
216.93%
EPS(YoY)
-3.03
42.66%
Analyst Rating
BUY
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
79.93%-0.21
71.76%-0.37
72.65%-0.29
69.16%-0.41
33.01%-1.05
7.67%-1.31
24.49%-1.05
-73.87%-1.32
-84.89%-1.56
-58.98%-1.42
-4.16%-1.39
---0.76
---0.84
---0.89
---1.33
---3.72
----
----
----
----
Revenue
88.02%74.27M
104.43%58.30M
94.12%57.58M
202.74%49.50M
439.36%39.50M
1391.58%28.52M
4249.56%29.66M
--16.35M
--7.32M
--1.91M
--682.00K
----
----
----
----
----
----
----
----
----
Net Profit
----
67.80%-30.37M
71.59%-21.15M
64.98%-29.97M
17.10%-75.81M
-13.84%-94.32M
6.43%-74.45M
-97.90%-85.58M
-123.23%-91.45M
-119.10%-82.85M
-44.55%-79.57M
15.36%-43.24M
19.55%-40.97M
7.01%-37.81M
-53.65%-55.05M
-39.36%-51.09M
-39.31%-50.92M
-16.71%-40.66M
33.31%-35.83M
-7.50%-36.66M
Net Margin
----
84.25%-52.09%
85.37%-36.73%
88.43%-60.55%
84.63%-191.91%
92.37%-330.71%
97.85%-250.98%
---523.34%
---1248.58%
---4333.26%
---11667.16%
----
----
----
----
----
----
----
----
----
Gross Margin
-8.68%79.68%
-8.65%79.42%
-0.48%86.72%
2.22%87.50%
7.43%87.25%
11.87%86.94%
15.40%87.14%
--85.59%
--81.21%
--77.72%
--75.51%
----
----
----
----
----
----
----
----
----
Debt to assets ratio
-26.72%168.00%
-6.95%178.48%
54.41%226.30%
80.38%241.55%
44.84%229.27%
46.10%191.81%
36.37%146.56%
41.02%133.92%
92.54%158.28%
-10.53%131.28%
-13.51%107.47%
--94.96%
--82.21%
--146.74%
--124.26%
--97.89%
----
----
----
----
Income Statement
Revenue
88.02%74.27M
104.43%58.30M
94.12%57.58M
202.74%49.50M
439.36%39.50M
1391.58%28.52M
4249.56%29.66M
--16.35M
--7.32M
--1.91M
--682.00K
----
----
----
----
----
----
----
----
----
Operating profit
92.36%-3.96M
80.37%-15.48M
90.02%-5.93M
80.12%-14.07M
32.83%-51.92M
-12.74%-78.86M
14.97%-59.42M
-98.54%-70.80M
-143.84%-77.30M
-132.58%-69.95M
-49.81%-69.88M
16.15%-35.66M
30.12%-31.70M
20.65%-30.08M
-41.17%-46.64M
-28.34%-42.53M
-28.44%-45.36M
-12.87%-37.91M
36.99%-33.04M
-0.94%-33.14M
Net Profit
----
67.80%-30.37M
71.59%-21.15M
64.98%-29.97M
17.10%-75.81M
-13.84%-94.32M
6.43%-74.45M
-97.90%-85.58M
-123.23%-91.45M
-119.10%-82.85M
-44.55%-79.57M
15.36%-43.24M
19.55%-40.97M
7.01%-37.81M
-53.65%-55.05M
-39.36%-51.09M
-39.31%-50.92M
-16.71%-40.66M
33.31%-35.83M
-7.50%-36.66M
Balance Sheet
Current assets
35.20%295.92M
4.41%276.57M
-36.42%228.97M
-44.42%207.78M
-28.19%218.88M
-22.16%264.90M
-9.38%360.13M
64.88%373.82M
18.26%304.79M
143.35%340.31M
147.60%397.43M
14.62%226.73M
23.16%257.72M
-4.05%139.84M
-13.95%160.51M
-12.21%197.81M
-0.98%209.26M
-39.98%145.74M
-35.98%186.53M
-0.81%225.31M
Total current liabilities
67.47%153.78M
68.90%125.04M
54.03%132.04M
42.63%93.12M
95.33%91.82M
70.35%74.03M
121.06%85.73M
172.27%65.29M
118.19%47.01M
200.90%43.46M
47.81%38.78M
4.81%23.98M
2.23%21.55M
26.76%14.44M
38.67%26.24M
-17.73%22.88M
-46.80%21.07M
-72.10%11.39M
-65.92%18.92M
0.51%27.81M
Total assets
30.71%327.07M
3.71%305.12M
-31.50%259.15M
-37.92%240.29M
-21.65%250.22M
-17.47%294.21M
-8.58%378.32M
63.32%387.04M
20.50%319.38M
147.55%356.50M
151.10%413.84M
17.36%236.99M
24.14%265.04M
-3.38%144.01M
-13.00%164.81M
-11.58%201.93M
-0.50%213.50M
-39.50%149.05M
-35.81%189.43M
-1.09%228.38M
Total liabilities
2.33%671.35M
1.50%642.08M
10.35%697.32M
15.44%662.82M
18.59%656.05M
25.26%632.58M
29.86%631.90M
125.37%574.16M
123.57%553.21M
115.62%505.00M
103.07%486.60M
11.57%254.76M
12.22%247.44M
110.97%234.21M
104.33%239.62M
82.84%228.35M
167.43%220.50M
35.34%111.01M
16.30%117.28M
67.64%124.90M
Total equity
15.17%-344.27M
0.42%-336.95M
-72.79%-438.17M
-125.82%-422.53M
-73.56%-405.83M
-127.86%-338.38M
-248.52%-253.58M
-952.79%-187.11M
-1428.57%-233.83M
-64.65%-148.50M
2.75%-72.76M
32.74%-17.77M
351.43%17.60M
-337.14%-90.19M
-203.68%-74.81M
-125.53%-26.42M
-105.30%-7.00M
-76.86%38.03M
-62.86%72.16M
-33.83%103.48M
Cash Flow Statement
Net operating income
96.92%-1.93M
81.58%-15.65M
92.12%-5.00M
77.80%-14.12M
11.30%-62.73M
-23.05%-84.93M
-44.89%-63.46M
-99.20%-63.57M
-218.56%-70.72M
-73.99%-69.02M
-7.62%-43.80M
8.86%-31.91M
13.67%-22.20M
11.37%-39.67M
1.37%-40.70M
-20.47%-35.02M
9.34%-25.72M
10.06%-44.76M
-46.32%-41.26M
-40.23%-29.07M
Net investment
54.64%-44.00K
-238.89%-61.00K
-1640.00%-87.00K
38.64%-27.00K
-110.87%-97.00K
55.00%-18.00K
98.95%-5.00K
95.31%-44.00K
-666.67%-46.00K
81.31%-40.00K
-15.29%-475.00K
-600.75%-939.00K
98.60%-6.00K
-219.40%-214.00K
-312.00%-412.00K
-857.14%-134.00K
-851.11%-428.00K
60.36%-67.00K
19.35%-100.00K
92.35%-14.00K
Net financing
4338.75%3.55M
--66.64M
-100.37%-97.00K
-100.22%-271.00K
-99.68%80.00K
-100.00%0.00
-87.71%26.05M
938800.00%122.06M
-82.49%24.77M
-29.65%9.90M
--211.99M
-99.95%13.00K
48.25%141.50M
--14.07M
-100.00%0.00
-44.14%24.60M
91675.00%95.45M
-100.00%0.00
-99.82%163.00K
--44.03M

FAQs

What is the total revenue of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its total revenue reached 175.11M, with a year-on-year change of 55.25M.

What are the current assets of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its current assets were 228.97M, with a year-on-year change of -36.42.

What are the total assets of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its total assets of Phathom Pharmaceuticals Inc were 259.15M, with a year-on-year change of -31.50.

What are the total liabilities of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its total liabilities of Phathom Pharmaceuticals Inc were 697.32M, with a year-on-year change of 10.35.

What is the total equity of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its total equity of Phathom Pharmaceuticals Inc was -438.17M, with a year-on-year change of -72.79.

What is the net operating income of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its net operating income of Phathom Pharmaceuticals Inc was -150.79M, with a year-on-year change of 45.66.

What is the net investment of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its net investment of Phathom Pharmaceuticals Inc was -229.00K, with a year-on-year change of -69.63.

What is the net financing of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its net financing of Phathom Pharmaceuticals Inc was -288.00K, with a year-on-year change of -100.16.

What is the Earnings Per Share (EPS) of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.03, with a year-on-year change of 42.66.

What is the net income of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its net income was -221.25M, with a year-on-year change of 33.82.

What is the net margin of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its net profit margin was -126.35, with a year-on-year change of 79.12.

What is the gross margin of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its gross margin was 87.09, with a year-on-year change of 1.78.

What is the debt-to-asset ratio of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its debt-to-asset ratio was 226.30, with a year-on-year change of 54.41.

What is the Return on Assets (ROA) of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its Return on Assets (ROA) was -69.41, with a year-on-year change of 17.76.

What is the operating profit of Phathom Pharmaceuticals Inc?

According to Phathom Pharmaceuticals Inc's FY2025 earnings report, its operating profit was -150.79M, with a year-on-year change of 45.66.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy